Keystone Symposia

Snowbird Resort Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

This meeting took place in 2020



For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

MEETING CANCELLED: Asthma: Making New Discoveries into Better Therapies (D1)


Organizer(s) Michael J. Holtzman, Philippa C. Marrack, Anne I. Sperling and Prescott G. Woodruff
April 2—6, 2020
Snowbird Resort • Snowbird, UT USA
Discounted Abstract Deadline: Dec 3, 2019
Abstract Deadline: Jan 7, 2020
Scholarship Deadline: Dec 3, 2019
Discounted Registration Deadline: Feb 3, 2020

Supported by the Directors' Fund

Summary of Meeting:
Asthma and related diseases in the form of COPD and asthma-COPD are a remarkably common, affecting over 50 million patients in the US alone. Asthma is typically thought to arise from an aberrant type 2 immune response, but the cellular and molecular mechanisms that lead to asthma require more precise definition. In particular, a subset of patients have asthma that is associated with or exacerbated by aberrant non-type 2 immune mechanisms which are inadequately characterized. These patients respond poorly to currently available therapies and represent a significant unmet clinical need. Recent clinical trials of anti-asthma therapeutics have revealed both successes and also some unforeseen failures; thus, convening a high-level scientific conference that broadly addresses the state of the field is particularly timely and important. The 2020 Keystone Symposia conference on asthma will highlight the most recent basic science breakthroughs in the pathogenesis of asthma and related inflammatory airway diseases and focus on the development of new therapeutics for asthma, as well as related chronic lower respiratory disease, which is now the third most common cause of death in the U.S and the fifth most common worldwide. In addition, sessions of the program will review these discoveries in the context of new therapeutics and therapeutic directions, including precision medicine. The program has been designed to emphasize the immunological and interrelated non-immunological approaches to identify, validate, and translate new biological targets into new therapeutics. The topic is timely and urgent given the recent mechanistic insights into inflammatory airway disease and the current maturation of new biological therapies for asthma that are now just entering clinical application.

View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


Program is being updated. Please check back soon for program details.